BACKGROUND AND AIMS
Advances in cancer care have improved survival, increasing the importance of comorbidities at diagnosis for longer-term outcomes. Pre-existing cardiovascular disease (CVD) can complicate management and prognosis, yet its long-term trends and future burden at cancer diagnosis are unclear. This study...
A. Alshahrani, E. Kontopantelis, C. Morgan et al.· European Heart Journal· 0 citations
Overall survival was poorer in patients with cardiac comorbidity than in those without, particularly among those receiving a higher CAA dose, while absolute survival estimates suggested a clinically meaningful benefit of lower CAA dose among patients with pre-existing CVD, supporting the potential importance of CAA min...
C. Morgan, C. Finn, G. Price et al.· European Heart Journal, Supp...· 0 citations
The burden of pre-existing CVD at cancer diagnosis has increased substantially over the past two decades in the UK and is projected to rise further, highlighting the growing need for integrated prevention strategies and cardio-oncology services to address increasing multimorbidity in patients with cancer.
A. Alshahrani, E. Kontopantelis, C. Morgan et al.· European Heart Journal, Supp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.